Free Trial Information
BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...investor First Analysis joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises...
Read More
BioCentury | Oct 26, 1998
Company News

Bearsden board of directors update

...Bearsden Bio Inc., Aston, Penn. Business: Drug discovery Appointed: Patrick Burns, senior consultant to Early Stage Enterprises; and...
Read More
BioCentury | Aug 22, 1994
Finance

New Banexi fund to incorporate biotech

New Banexi fund to incorporate biotech Banexi Corp., the international merchant banking arm of Banque Nationale de Paris, and Nazem & Co., a Menlo Park, Calif., venture capital firm, announced plans to raise a $40-60...
Read More
Items per page:
1 - 3 of 3
BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...investor First Analysis joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises...
Read More
BioCentury | Oct 26, 1998
Company News

Bearsden board of directors update

...Bearsden Bio Inc., Aston, Penn. Business: Drug discovery Appointed: Patrick Burns, senior consultant to Early Stage Enterprises; and...
Read More
BioCentury | Aug 22, 1994
Finance

New Banexi fund to incorporate biotech

New Banexi fund to incorporate biotech Banexi Corp., the international merchant banking arm of Banque Nationale de Paris, and Nazem & Co., a Menlo Park, Calif., venture capital firm, announced plans to raise a $40-60...
Read More
Items per page:
1 - 3 of 3